Company: CERO
Filing Date: 2025-05-27
Form Type: POS AM
Source: 0001213900-25-047469
Chunk: 253

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-05-27
Form: POS AM
Chunk 253
---
 |
| Michael Byrnes(6)                                                           |     |              |   9,024 |     |              |     * |   |
| Kathleen LaPorte(7)                                                         |     |              |  18,743 |     |              |     * |   |
| Lindsey Rolfe, M.D.(8)                                                      |     |              |   9,024 |     |              |     * |   |
| Shami Patel(9)                                                              |     |              |   7,529 |     |              |     * |   |
| All current directors and executive officers as a group (eight individuals) |     |              | 903,672 |     |              | 10.24 | % |

| * | Represents beneficial ownership of less than 1% of our outstanding 
 Common Stock.                                                      |

| (1) | Unless otherwise noted, the business address of each of the                         
 following individuals is 210 Haskins Way, Suite 230, South San Francisco, CA 94080. |

| (2) | Consists of (i) 57,919 shares of Common Stock, (ii) 50 shares                                                                          
 of Common Stock issuable upon the exercise of Warrants exercisable within 60 days of May 19, 2025, (iii) 78,605 shares of Common Stock 
 issuable pursuant to stock options exercisable within 60 days of May 19, 2025, and (iv) 36 shares of Common Stock held by his spouse,  
 Sara Fried.                                                                                                                            |

| (3) | Consists of 3,750 shares of Common Stock, issuable pursuant  
 to stock options exercisable within 60 days of May 19, 2025. |

| (4) | Consists of 1,409 shares of Common Stock issuable pursuant to 
 stock options exercisable within 60 days of May 19, 2025.     |

| (5) | Consists of (i) 1,250 shares of Common Stock, (ii) 490,534 shares of Common Stock, held by the                                               
 Atwood-Edminster Trust dtd 4-2-2000 (the “Trust”), of which Mr. Atwood and Lynne H. Edminster serve as trustees (iii)                        
 10,059 shares of Common Stock, issuable pursuant to stock options exercisable within 60 days of May 19, 2025 and (